8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications
Top Cited Papers
Open Access
- 1 October 2013
- journal article
- review article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 7, 1157-78
- https://doi.org/10.2147/dddt.s49763
Abstract
Peer reviewed article authored by (Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V). Read article or submit your manuscript for publishing.Keywords
This publication has 105 references indexed in Scilit:
- The Epidemiology of Lead Toxicity in Adults: Measuring Dose and Consideration of Other Methodologic IssuesEnvironmental Health Perspectives, 2007
- Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease1Journal of Neurochemistry, 2006
- Monensin Improves the Effectiveness of meso -Dimercaptosuccinate when Used to Treat Lead Intoxication in RatsEnvironmental Health Perspectives, 2006
- The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategyBritish Journal of Pharmacology, 2005
- 8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-κB and C/EBPβ in Raw 264.7 cellsBiochemical and Biophysical Research Communications, 2005
- Copper and carcinogenesisCritical Reviews in Oncology/Hematology, 2002
- Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumorsJournal of Neuro-Oncology, 1993
- Rapid and sensitive detection of hydroxyl radicals formed by activated neutrophils in the presence of chelated iron: Hydroxylation of deoxyguanosine to 8-hydroxydeoxyguanosineInflammation Research, 1992
- Requirements for Sod Mimics OperatingIn Vitroto Work AlsoIn VivoFree Radical Research Communications, 1991
- Serum ceruloplasmin and copper levels in patients with primary brain tumorsKlinische Wochenschrift, 1984